US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74

-0.0600-0.34%

Post-market: 17.800.0600+0.34%19:30 EDT

Volume:28.78K

Turnover:509.79K

Market Cap:104.67M

PE:- -

High:17.93

Open:17.89

Low:17.60

Close:17.80

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.55

T/O Rate:0.49%

Dividend:0.71

Dividend Rate:4.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices

China's Joinn Laboratories H1 Profit Jumps 1,127% on Strong Drug Demand

Hong Kong's Frontage Holdings H1 Profit More than Doubles on Teddy Lab Acquisition

CSPC Pharmaceutical Group Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Akeso Says Phase III Ivonescimab-Chemo Trial in Biliary Tract Cancer Meets Overall Survival Endpoint

Press Release: Akeso 2026 Interim Results: Strong Commercialization Momentum; Io2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's

CMB International Lifts WUXI BIO Price Target to HK$60, Maintains "Buy" Rating

Akeso's Losses Narrow in H1 as Revenue Climbs 28%

MT Newswires Live

Earnings Beat: Innovent Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Simply Wall St.

Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares

Akeso FY26 H1 Net Loss Narrows 23.98% to RMB 447.2 Million; Revenue Rises 27.92% to RMB 1.81 Billion

Nomura Adjusts Innovent Biologics' Price Target to HK$125 From HK$105, Keeps at Buy

MT Newswires Live

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

CSPC Pharma Gets Trial Nod for Weight Management Drug in China

MT Newswires Live

CSPC Pharma's High-Activity Amylin Receptor Agonist Gets Green Light for Clinical Trials in China

CSPC Wins China Clinical Trial Approval for Syh2092 Amylin Agonist Injection

CSPC Pharmaceutical - Pharma Obtains China Clinical Trial Approval for Syh2092 Injection

THOMSON REUTERS

CSPC Pharmaceutical - Highly Potent Amylin Receptor Agonist (Syh2092 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Biocytogen Pharmaceuticals H1 Revenue up 51.6%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/KURE/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.74,"timestamp":1789156800000,"preClose":17.8,"halted":0,"volume":28778,"hourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"delay":0,"changeRate":-0.00337078651685406,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Market Closed","change":-0.06,"latestTime":"09-11 16:00:00 EDT","open":17.89,"high":17.93,"low":17.6,"amount":509789.147232,"amplitude":0.018539,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.8,"sharesOutstanding":4750002,"nav":17.98,"aum":106101372.73,"dividendRate":0.040293,"bidAskSpread":0.008302,"postHourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"volumeRatio":0.5515710695008692,"impliedVol":0.3113,"impliedVolPercentile":0.6295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5515710695008692,"shares":5900168,"dividePrice":0.7148,"high":17.93,"amplitude":0.018539,"preClose":17.8,"low":17.6,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.74,"eps":0,"divideRate":0.040293,"volume":28778,"delay":0,"ttmEps":0,"open":17.89,"prevYearClose":17.04,"prevWeekClose":18.9,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.91,"twentyDayClose":18.66,"sixtyDayClose":14.875},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662172061","title":"China's Dawnrays Pharmaceutical H1 Revenue Falls on Lower Procurement Prices","url":"https://stock-news.laohu8.com/highlight/detail?id=2662172061","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662172061?lang=en_us&edition=fundamental","pubTime":"2026-08-28 18:28","pubTimestamp":1787912881,"startTime":"0","endTime":"0","summary":"China's Dawnrays Pharmaceutical H1 revenue falls on lower procurement pricesOverviewChina pharmaceutical maker's interim revenue fell 13.4% yr/yr on lower sales of key productsProfit attributable to o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0BX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU0463099449.HKD","LU1969619763.USD","BK1606","02348","KURE","LU2097828557.USD","BK1583","LU2488822045.USD","LU0455707207.USD","01801","LU2097828714.EUR","LU2097828805.USD","LU2242644610.SGD","LU2328871848.SGD","BK1191","BK1161","BK1589","LU1188198961.HKD","03737","LU0502904849.HKD","LU0244354667.USD","LU0326950275.SGD","HK0000165453.HKD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066488","title":"China's Joinn Laboratories H1 Profit Jumps 1,127% on Strong Drug Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066488","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662066488?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:54","pubTimestamp":1787910858,"startTime":"0","endTime":"0","summary":"China's Joinn Laboratories H1 profit jumps 1,127% on strong drug demandOverviewChina CRO services provider's interim revenue grew 5.3% yr/yr, net income surged 1,126.8%Company attributed growth to mar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0B3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","LU0417516902.SGD","LU0588546209.SGD","LU0819121731.USD","06127","LU1794554557.SGD","BK1521","LU0029874061.USD","IE00B0JY6N72.USD","LU2039709279.SGD","LU0326950275.SGD","LU1146622755.USD","LU0979878070.USD","LU0572944931.SGD","LU0823426308.USD","300347","LU0348735423.USD","LU0181495838.USD","BK0077","BK1610","LU0417516738.SGD","LU0052750758.USD","BK0174","LU0039217434.USD","LU0320764599.SGD","LU0051755006.USD","01873","BK0028","LU0307460666.USD","LU0327786744.USD","LU0140636845.USD","LU0359201612.USD","LU0856984785.SGD","LU1242518931.SGD","LU1720050803.USD","603127","LU0516422440.USD","LU1880383366.USD","BK0216","LU0516422366.SGD","SG9999002463.SGD","LU0516422952.EUR","02269","LU3063872942.SGD","KURE","LU0708995583.HKD","LU1688375341.USD","LU0456846285.SGD","LU0043850808.USD","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662078065","title":"Hong Kong's Frontage Holdings H1 Profit More than Doubles on Teddy Lab Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2662078065","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662078065?lang=en_us&edition=fundamental","pubTime":"2026-08-28 17:43","pubTimestamp":1787910206,"startTime":"0","endTime":"0","summary":"Hong Kong's Frontage Holdings H1 profit more than doubles on Teddy Lab acquisitionOverviewHong Kong-based CRO's H1 revenue rose 17% yr/yr to $148.2 mlnNet profit for H1 more than doubled to $6.8 mlnCo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nL1N44P0AU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300347","LU0043850808.USD","LU0856984785.SGD","01521","LU0140636845.USD","LU0052750758.USD","LU0327786744.USD","LU0823426308.USD","BK0216","LU0572944931.SGD","LU0417516902.SGD","LU0979878070.USD","LU0029874061.USD","02269","BK0028","LU0456846285.SGD","BK1141","LU0128526141.USD","LU1720050803.USD","LU0326950275.SGD","LU1146622755.USD","BK1521","LU0320764599.SGD","LU2039709279.SGD","LU1880383366.USD","LU0039217434.USD","LU0516422366.SGD","LU1242518931.SGD","LU0348735423.USD","BK0077","BK1589","LU0181495838.USD","LU1688375341.USD","LU0819121731.USD","BK0174","LU3063872942.SGD","LU0588546209.SGD","LU0708995583.HKD","IE00B0JY6N72.USD","LU0307460666.USD","SG9999002463.SGD","LU0516422440.USD","KURE","LU0516422952.EUR","BK1610","LU0051755006.USD","BK1583","LU0417516738.SGD","LU0359201612.USD","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662050237","title":"CSPC Pharmaceutical Group Stock Sheds 1.5% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662050237","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662050237?lang=en_us&edition=fundamental","pubTime":"2026-08-28 16:32","pubTimestamp":1787905920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. shed 1.5% to 9.53 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.1% to 25584.79.The stock's fall snapped a four-day winning streak.CSPC Pharmaceutical Group Ltd. closed 18% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. fell 0.7%, SSY Group Ltd. rose 0.4%, and United Laboratories International Holdings Ltd. fell 1.8%.Trading volume totaled 74.5 million shares, compared to the 50-day average of 104.3 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","LU0067412154.USD","LU2039709279.SGD","LU1226287792.SGD","HK0000165453.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B031HY20.USD","01093","LU1226288253.USD","IE00B543WZ88.USD","LU0140636845.USD","LU1226288170.HKD","LU1993786604.SGD","LU1152091168.USD","LU0880133367.SGD","SG9999004220.SGD","LU1960683339.HKD","LU0501845795.SGD","BK1191","LU0072913022.USD","IE00BZ08YT58.USD","LU1813983027.USD","LU1226287529.USD","LU0326950275.SGD","LU1152091754.HKD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1951186391.HKD","LU0314109678.HKD","BK1515","KURE","IE0008368742.USD","LU0315179316.USD","LU1807302812.USD","LU1008478684.HKD","IE00BZ08YS42.EUR","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662936058","title":"Akeso Says Phase III Ivonescimab-Chemo Trial in Biliary Tract Cancer Meets Overall Survival Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2662936058","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662936058?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:45","pubTimestamp":1787885130,"startTime":"0","endTime":"0","summary":"Akeso says Phase III ivonescimab-chemo trial in biliary tract cancer meets overall survival endpointAkeso highlighted late-stage gains for ivonescimab, with a Phase III first-line biliary tract cancer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL6VxC1X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2399975544.HKD","LU0348784397.USD","LU2778985437.USD","IE00B543WZ88.USD","LU2476274308.USD","LU1961090484.USD","LU1794554557.SGD","BK1574","IE00B5MMRT66.SGD","LU0417516902.SGD","LU0348825331.USD","LU0348783233.USD","LU1720050803.USD","LU2488822045.USD","LU0348827113.USD","LU0348735423.USD","LU0540923850.HKD","LU0417516571.SGD","09926","KURE","LU0634319403.HKD","LU2476274720.SGD","LU0561508036.HKD","IE00BPRC5H50.USD","LU0348766576.USD","LU0348767384.USD","LU0417516738.SGD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662058969","title":"Press Release: Akeso 2026 Interim Results: Strong Commercialization Momentum; Io2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's","url":"https://stock-news.laohu8.com/highlight/detail?id=2662058969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662058969?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:45","pubTimestamp":1787885100,"startTime":"0","endTime":"0","summary":"HONG KONG, Aug. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) (\"Akeso\" or the \"Company\") announced its 2026 interim results. During the reporting period, the Company achieved record-high drug sales r","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COAL","BK4195","KURE","PFS","IE00BFMHRM44.USD","LU2476274720.SGD","LU0561508036.HKD","LU1720051108.HKD","LU1720050803.USD","BK4211","LU1854103824.USD","BK4141","LU0348766576.USD","LU0417516571.SGD","BK4135","IE00B5MMRT66.SGD","LU2357305700.SGD","BK4588","LU0348825331.USD","ON","LU1548497426.USD","LU1983260115.SGD","BK4585","BK4006","LU0417516902.SGD","LU0634319403.HKD","IE00BPRC5H50.USD","LU1861214812.USD","BK4512","LU2298322129.HKD","LU2399975544.HKD","LU1720051017.SGD","HCC","LU1794554557.SGD","LU0348723411.USD","LU1854104046.USD","BK1161","LU1861220033.SGD","LU2778985437.USD","LU1861215975.USD","LU2360107325.USD","IE00B543WZ88.USD","09926","LU0348784397.USD","CNS","ONX","ONG","LU0348735423.USD","LU0348827113.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145217194","title":"CMB International Lifts WUXI BIO Price Target to HK$60, Maintains \"Buy\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1145217194","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145217194?lang=en_us&edition=fundamental","pubTime":"2026-08-28 10:44","pubTimestamp":1787885052,"startTime":"0","endTime":"0","summary":"CMB International has released a research report highlighting WUXI BIO (02269)'s strong first-half performance, which prompted an upward revision of its full-year revenue growth guidance to 15%-18%....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","LU0043850808.USD","LU0708995583.HKD","LU1794554557.SGD","LU1720050803.USD","LU0823426308.USD","LU0029874061.USD","LU0326950275.SGD","LU0823426480.USD","LU1688375341.USD","LU0456827905.SGD","LU2039709279.SGD","BK1610","PRTO","SG9999002562.SGD","LU0181495838.USD","LU0516422440.USD","LU3063872942.SGD","BK1589","LU0417516902.SGD","LU0516422952.EUR","LU0572944931.SGD","LU0588546209.SGD","LU1880383366.USD","LU0128526141.USD","BK1141","KURE","LU0516423174.USD","BK1576","LU0348735423.USD","LU0516422366.SGD","SG9999002463.SGD","BK1521","LU0051755006.USD","LU0417516738.SGD","LU0039217434.USD","LU0456846285.SGD","LU0856984785.SGD","LU0052750758.USD","LU0327786744.USD","LU1242518857.USD","LU0320764599.SGD","EWH","LU0516423091.SGD","LU0140636845.USD","02269","LU1242518931.SGD","IE00B0JY6N72.USD","LU0307460666.USD","LU0359201612.USD","LU0979878070.USD","LU0359202008.SGD","LU0819121731.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662203452","title":"Akeso's Losses Narrow in H1 as Revenue Climbs 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662203452","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662203452?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:06","pubTimestamp":1787875618,"startTime":"0","endTime":"0","summary":"Akeso  reported an attributable loss of 424.2 million yuan for the first half, narrowing from a loss of 570.1 million a year earlier.Loss per share stood at 0.46 yuan, compared with 0.64 yuan in the year-ago period, according to a Thursday filing with the Hong Kong Exchange.The biotech company's revenue increased 28% year over year to 1.81 billion yuan for the six months ended June 30 from 1.41 billion yuan.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LU1794554557.SGD","IE00B543WZ88.USD","LU0634319403.HKD","LU0348767384.USD","LU0348784397.USD","LU0417516738.SGD","IE00B5MMRT66.SGD","LU0348766576.USD","LU0561508036.HKD","LU2476274308.USD","09926","FCA","LU0348735423.USD","IE00BPRC5H50.USD","LU0417516571.SGD","BK1574","LU1720050803.USD","LU0348827113.USD","LU2778985437.USD","LU0348825331.USD","LU2399975544.HKD","LU0417516902.SGD","LU2476274720.SGD","LU0540923850.HKD","KURE","LU0348783233.USD","LU1961090484.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662378920","title":"Earnings Beat: Innovent Biologics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models","url":"https://stock-news.laohu8.com/highlight/detail?id=2662378920","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662378920?lang=en_us&edition=fundamental","pubTime":"2026-08-28 06:45","pubTimestamp":1787870742,"startTime":"0","endTime":"0","summary":"It's been a good week for Innovent Biologics, Inc. ( HKG:1801 ) shareholders, because the company has just released its...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/earnings-beat-innovent-biologics-inc-just-beat-analyst-forec","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/earnings-beat-innovent-biologics-inc-just-beat-analyst-forec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2097828474.EUR","FEBU","LU2097828557.USD","LU1969619763.USD","01801","LU2242644610.SGD","LU1188198961.HKD","LU0463099449.HKD","GXDW","VGFPF","LU0455707207.USD","LU2097828714.EUR","LU2097828805.USD","BK1589","PMDE","DECU","LU2328871848.SGD","JOYT","LU2488822045.USD","VOTE","BK1583","LU0326950275.SGD","RGLO","KURE","HK0000165453.HKD","LU0244354667.USD","LU0502904849.HKD","LU2097828631.EUR","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086799","title":"Innovent Biologics Files HKEX Next-Day Disclosure Return, Issues 182,021 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086799","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662086799?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:51","pubTimestamp":1787842274,"startTime":"0","endTime":"0","summary":"Innovent Biologics files HKEX next-day disclosure return, issues 182,021 new sharesInnovent filed a next-day disclosure return on Aug. 27, 2026 for share issuances from option exercises.Issued 182,021","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL82CCyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","LU2097828631.EUR","LU0463099449.HKD","01911","LU2097828714.EUR","KURE","BK1147","LU1188198961.HKD","LU2242644610.SGD","LU1969619763.USD","LU2097828805.USD","BK1589","LU0326950275.SGD","HK0000165453.HKD","LU0455707207.USD","LU2328871848.SGD","01801","BK1161","LU2097828474.EUR","LU0244354667.USD","LU2097828557.USD","LU2488822045.USD","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662790083","title":"Akeso FY26 H1 Net Loss Narrows 23.98% to RMB 447.2 Million; Revenue Rises 27.92% to RMB 1.81 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2662790083","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662790083?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:00","pubTimestamp":1787839249,"startTime":"0","endTime":"0","summary":"Akeso FY26 H1 net loss narrows 23.98% to RMB 447.2 million; revenue rises 27.92% to RMB 1.81 billionAkeso posted revenue of RMB 1.81 billion, up 27.92% year over year, driven mainly by cadonilimab and","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL34jFkn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","LU0348784397.USD","LU0561508036.HKD","LU0348783233.USD","LU0348825331.USD","LU2399975544.HKD","LU1794554557.SGD","IE00BPRC5H50.USD","LU0540923850.HKD","LU0417516571.SGD","LU2778985437.USD","LU1720050803.USD","IE00B5MMRT66.SGD","BK1161","IE00B543WZ88.USD","LU2476274308.USD","LU0417516738.SGD","LU2476274720.SGD","LU2488822045.USD","KURE","LU0417516902.SGD","BK1574","LU1961090484.USD","LU0348766576.USD","LU0634319403.HKD","LU0348735423.USD","LU0348827113.USD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662980702","title":"Nomura Adjusts Innovent Biologics' Price Target to HK$125 From HK$105, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2662980702","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662980702?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:05","pubTimestamp":1787832345,"startTime":"0","endTime":"0","summary":"Innovent Biologics (HKG:1801) has an average rating of buy and mean price target of HK$127.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["01801","BK1161","LU0502904849.HKD","LU2097828714.EUR","LU1969619763.USD","BK1583","LU2488822045.USD","LU2242644610.SGD","LU1188198961.HKD","LU0244354667.USD","LU0455707207.USD","HK0000165453.HKD","LU2328871848.SGD","LU2097828631.EUR","LU2097828474.EUR","LU0326950275.SGD","LU2097828557.USD","LU0463099449.HKD","KURE","BK1589","LU2097828805.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662046377","title":"China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662046377","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662046377?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:40","pubTimestamp":1787830849,"startTime":"0","endTime":"0","summary":"China's CStone Pharmaceuticals H1 revenue soars on drug salesOverviewChina biopharma firm's half-year revenue rose 315% yr/yr to RMB205.1 mlnRevenue growth driven by higher pharmaceutical sales, espec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0IS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0216","BK1589","BK1161","BK1191","LU0463099449.HKD","LU2097828805.USD","LU1188198961.HKD","LU1969619763.USD","HK0000165453.HKD","02616","BK1574","03692","LU2097828557.USD","LU2488822045.USD","688796","LU0244354667.USD","LU2097828631.EUR","LU2328871848.SGD","LU2097828714.EUR","LU0502904849.HKD","LU2242644610.SGD","LU2097828474.EUR","LU0455707207.USD","01801","BK1583","LU0326950275.SGD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662457709","title":"CSPC Pharma Gets Trial Nod for Weight Management Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662457709","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662457709?lang=en_us&edition=fundamental","pubTime":"2026-08-27 19:05","pubTimestamp":1787828740,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group  obtained clinical trial approval for the SYH2092 injection from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.The product has the potential to bring significant clinical benefits for weight management in patients with obesity and improve glycaemic control in patients with type 2 diabetes mellitus.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1152091168.USD","LU1813983027.USD","BK1521","LU0326950275.SGD","HK0000165453.HKD","LU0501845795.SGD","BK1191","LU1226287875.USD","LU0067412154.USD","LU1152091754.HKD","KURE","LU1328277881.USD","BK1515","LU1226287792.SGD","LU0072913022.USD","LU0140636845.USD","LU1807302812.USD","IE0008369823.USD","IE00B031HY20.USD","LU0315179316.USD","LU1993786604.SGD","SG9999004220.SGD","IE0008368742.USD","01093","LU1226288253.USD","LU1951186391.HKD","LU1960683339.HKD","IE00B543WZ88.USD","LU0880133367.SGD","LU1008478684.HKD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1226288170.HKD","LU0314109678.HKD","IE00BZ08YT58.USD","IE00B5MMRT66.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191071495","title":"CSPC Pharma's High-Activity Amylin Receptor Agonist Gets Green Light for Clinical Trials in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1191071495","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191071495?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:30","pubTimestamp":1787826628,"startTime":"0","endTime":"0","summary":"CSPC PHARMA (01093) has announced that its developed SYH2092 injection has received approval from China's National Medical Products Administration to proceed with clinical trials within the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1226287529.USD","KURE","IE00BZ08YT58.USD","LU0326950275.SGD","01093","LU0140636845.USD","LU1813983027.USD","IE00B5MMRT66.SGD","PSYK","LU1226287875.USD","LU0501845795.SGD","LU0067412154.USD","LU1152091168.USD","LU1807302812.USD","BMED","LU0315179316.USD","LU1008478684.HKD","LU0314109678.HKD","LU0880133367.SGD","LU2039709279.SGD","LU1328277881.USD","BK1521","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1951186391.HKD","LU1226287792.SGD","LU1152091754.HKD","SG9999004220.SGD","BK1515","IE0008369823.USD","IE0008368742.USD","IBBQ","LU1960683339.HKD","MDTX","LU1993786604.SGD","HK0000165453.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226288253.USD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","IBBJ","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703286","title":"CSPC Wins China Clinical Trial Approval for Syh2092 Amylin Agonist Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703286","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703286?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:19","pubTimestamp":1787825977,"startTime":"0","endTime":"0","summary":"CSPC wins China clinical trial approval for SYH2092 amylin agonist injectionCSPC won China NMPA clearance to start clinical trials of SYH2092, an amylin receptor agonist injection for obesity.Program ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL60gfrb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0501845795.SGD","LU0326950275.SGD","LU1226287875.USD","HK0000165453.HKD","IE00BZ08YT58.USD","IE0008369823.USD","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","01093","LU0140636845.USD","LU0067412154.USD","BK1191","BK1515","LU1226288170.HKD","LU1226287792.SGD","LU2039709279.SGD","LU1152091168.USD","LU1951186391.HKD","LU1226288253.USD","KURE","LU1328277881.USD","LU0880133367.SGD","LU1813983027.USD","LU1960683339.HKD","IE0008368742.USD","SG9999004220.SGD","LU1993786604.SGD","IE00B543WZ88.USD","LU0315179316.USD","IE00B031HY20.USD","LU1226287529.USD","LU1008478684.HKD","LU1807302812.USD","LU0314109678.HKD","LU0072913022.USD","BK1521","LU1152091754.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703472","title":"CSPC Pharmaceutical - Pharma Obtains China Clinical Trial Approval for Syh2092 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662703472?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:19","pubTimestamp":1787825949,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O10A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1226287529.USD","KURE","IE00BZ08YT58.USD","LU0326950275.SGD","01093","LU0140636845.USD","LU1813983027.USD","IE00B5MMRT66.SGD","LU1226287875.USD","LU0501845795.SGD","LU0067412154.USD","LU1152091168.USD","LU1807302812.USD","LU0315179316.USD","LU1008478684.HKD","LU0314109678.HKD","LU0880133367.SGD","LU2039709279.SGD","LU1328277881.USD","BK1521","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1951186391.HKD","LU1226287792.SGD","LU1152091754.HKD","SG9999004220.SGD","BK1515","IE0008369823.USD","IE0008368742.USD","LU1960683339.HKD","LU1993786604.SGD","HK0000165453.HKD","LU1226288170.HKD","LU0072913022.USD","LU1226288253.USD","IE00B543WZ88.USD","IE00BZ08YS42.EUR","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662471703","title":"CSPC Pharmaceutical - Highly Potent Amylin Receptor Agonist (Syh2092 Injection) Obtains Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2662471703","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662471703?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:19","pubTimestamp":1787825949,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O10A:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999004220.SGD","LU1152091754.HKD","LU0140636845.USD","LU1226288170.HKD","LU1960683339.HKD","KURE","IE00BZ08YS42.EUR","LU2039709279.SGD","LU0067412154.USD","LU0072913022.USD","LU0326950275.SGD","01093","LU1813983027.USD","LU1226287875.USD","LU0501845795.SGD","IE0008368742.USD","IE00BZ08YR35.GBP","BK1515","BK1521","LU1226287792.SGD","LU1807302812.USD","IE00B5MMRT66.SGD","LU1008478684.HKD","IE0008369823.USD","BK1191","LU0880133367.SGD","IE00B031HY20.USD","LU1226287529.USD","LU1226288253.USD","HK0000165453.HKD","LU1152091168.USD","LU1951186391.HKD","LU0315179316.USD","LU1993786604.SGD","LU0314109678.HKD","IE00BZ08YT58.USD","LU1328277881.USD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662708043","title":"China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2662708043","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662708043?lang=en_us&edition=fundamental","pubTime":"2026-08-27 18:08","pubTimestamp":1787825320,"startTime":"0","endTime":"0","summary":"China's JW Therapeutics interim revenue rises 4.7% on Carteyva salesOverviewChina cell immunotherapy developer's interim revenue grew 4.7% yr/yr, driven by Carteyva salesGross profit margin improved t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","MEDX","AGNG","IBB","LU0943347566.SGD","IXJ","FHLC","LU0463099449.HKD","IE000SO60NU8.SGD","LU2237443978.SGD","LU2097828714.EUR","KURE","IBBQ","IYH","LU0432979614.USD","LU1188198961.HKD","BK1574","CMI","LU0310799852.SGD","LU1934455863.HKD","PPH","RXL","VHT","ABBV","IE00BVYPNV92.GBP","LU2237443382.USD","TBXU","IE0004445239.USD","LU1037948897.HKD","BBH","FTXH","03692","REGN","LU0708994859.HKD","LU0868494617.USD","LU1934455277.USD","GLAM","LU0395794307.EUR","XLV","01801","LU0949170772.SGD","LU2362541513.USD","TRUH","MADE","IE00BN8TJ469.HKD","PJP","JDOC","02126","LU1244550577.SGD","LU0859254822.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662774568","title":"Biocytogen Pharmaceuticals H1 Revenue up 51.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662774568","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662774568?lang=en_us&edition=fundamental","pubTime":"2026-08-27 16:41","pubTimestamp":1787820113,"startTime":"0","endTime":"0","summary":"Biocytogen Pharmaceuticals H1 revenue up 51.6%OverviewChina biotech firm's H1 revenue rose 51.6% yr/yr to RMB941.4 mlnNet profit attributable to shareholders up 402.3% to RMB241.1 mlnCompany cites str","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL1N44O0B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0856984785.SGD","01801","LU1242518857.USD","LU0516423091.SGD","LU0455707207.USD","KURE","LU2097828631.EUR","LU3063872942.SGD","LU0320764599.SGD","IE00B0JY6N72.USD","LU0417516738.SGD","LU2328871848.SGD","BK1191","03692","02269","LU0456846285.SGD","LU1720050803.USD","LU0502904849.HKD","LU0823426308.USD","BK1161","BK1583","LU0039217434.USD","LU0572944931.SGD","LU0979878070.USD","LU1794554557.SGD","688796","LU0819121731.USD","LU0359202008.SGD","LU0516422440.USD","BK1521","LU0128526141.USD","LU2097828805.USD","LU0516422366.SGD","LU0348825331.USD","LU0516423174.USD","LU0823426480.USD","LU2097828474.EUR","LU2488822045.USD","LU0463099449.HKD","BK1576","LU0588546209.SGD","LU2039709279.SGD","LU0307460666.USD","LU0244354667.USD","LU0417516902.SGD","LU0051755006.USD","LU1880383366.USD","02315","LU0348735423.USD","LU0140636845.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}